hero section gradient
15 handpicked stocks

Climate-Proof Infrastructure Builders

Invest in the companies engineering our world to withstand climate challenges. These carefully selected stocks represent firms creating the infrastructure we need as extreme weather events increase - from flood protection to wildfire suppression and cooling systems.

Author avatar

Han Tan | Market Analyst

Published on June 17

Your Basket's Financial Footprint

Aggregate and breakdown of market capitalisation for the Climate-Proof Infrastructure Builders basket.

Key Takeaways for Investors:
  • Large-cap dominance generally implies lower volatility and more stable returns, closer to broad-market performance than high-growth baskets.
  • Suitable as a core holding, offering diversified exposure to infrastructure-related sectors rather than a speculative allocation.
  • Likely to deliver steady long-term appreciation; not designed for explosive short-term gains.
Total Market Cap
  • XYL: $35.83B

  • CARR: $50.91B

  • TT: $94.39B

  • Other

About This Group of Stocks

1

Our Expert Thinking

Climate adaptation isn't optional – it's necessary. These companies are building the infrastructure needed to protect against flooding, extreme heat, wildfires, and other climate impacts. As governments and corporations increase spending on climate resilience, these specialized firms are positioned for sustained growth.

2

What You Need to Know

This collection focuses on companies generating significant revenue from climate-proofing solutions. Unlike discretionary spending, investment in climate resilience is increasingly mandatory as extreme weather events become more frequent, creating a powerful tailwind for these stocks.

3

Why These Stocks

Each company was selected for its direct role in creating climate-resilient infrastructure. From water management systems and energy-efficient HVAC to wildfire suppression and resilient engineering, these market leaders provide the specialized solutions our changing world demands.

Why You'll Want to Watch These Stocks

🌊

Climate Events Are Accelerating

As extreme weather becomes more frequent, governments and businesses are rapidly increasing investment in resilient infrastructure. These companies are first in line for this surge in spending.

🔧

Essential, Not Optional Spending

Unlike discretionary projects, climate adaptation infrastructure is becoming mandatory. These companies provide solutions that communities and businesses simply cannot afford to ignore.

🏗️

The Next Infrastructure Boom

Climate resilience represents one of the largest infrastructure investment opportunities of the decade. These specialized firms have the expertise and solutions that will be in high demand.

Get the full story on this Basket. Read our detailed article on its risks and potential.

Read Full Insight

Why Invest with Nemo Money?

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

💰

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Discover More Opportunities

Tech Stocks (AI Valuation Reset) Present Potential Entry

Tech Stocks (AI Valuation Reset) Present Potential Entry

Recent market turmoil, driven by concerns over AI stock valuations, has led to a significant drop in global markets. This correction creates a potential opportunity to invest in fundamentally sound technology companies at more attractive prices.

Walmart Succession Plan Explained | Market Effects

Walmart Succession Plan Explained | Market Effects

Walmart announced a CEO transition, with veteran John Furner taking the helm, which could create opportunities for competitors. This leadership change at a retail giant may cause short-term uncertainty, potentially benefiting other major players in the retail space.

Biotech Buyout Candidates (Post-Merck Acquisition)

Biotech Buyout Candidates (Post-Merck Acquisition)

Merck's $9.2 billion acquisition of Cidara Therapeutics for its antiviral drug pipeline signals a broader industry trend. This creates an investment opportunity in other biotech companies with promising late-stage drugs that could become the next acquisition targets for pharmaceutical giants.

Frequently Asked Questions